Development of an in process control filtration-assisted chemiluminometric immunoassay to quantify foot and mouth disease virus (FMDV) non-capsid proteins in vaccine-antigen batches

Vaccine

Volumn 28, Issue 40, 2010, Pages 6647-6652

  Capozzo, Alejandra Victoria ^a   Martínez, Manuel Rosendo ^b   Schielen, Wilhelmus Joseph Gerardus ^c  

^a Instituto de Ciencia y Tecnología Dr Cesar Milstein   (Argentina)

^b Fundación de Estudios en Virología Animal   (Argentina)

^c Prionics Lelystad BV   (Netherlands)

Author keywords

Antigen purity; Filtration assisted immunoassay; FMD vaccines; In process control tests; Vaccine quality control

Indexed keywords

CAPSID PROTEIN; LUMINOL; MONOCLONAL ANTIBODY; NON CAPSID PROTEIN; PEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FILTRATION ASSISTED CHEMILUMINOMETRIC IMMUNOASSAY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNOASSAY; INCUBATION TIME; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROCESS CONTROL; WESTERN BLOTTING;

ANTIBODIES, IMMOBILIZED; ANTIBODIES, MONOCLONAL; CHEMILUMINESCENT MEASUREMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FILTRATION; FOOT-AND-MOUTH DISEASE VIRUS; QUALITY CONTROL; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 77956396349     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.05.049     Document Type: Article

References (19)

1. Rueckert R.R., Wimmer E. Systematic nomenclature of picornavirus proteins. J Virol 1984, 50(June (3)):957-959.
2. Bergmann I.E., Neitzert E., Malirat V., de Mendonca Campos R., Pulga M., Muratovik R., et al. Development of an inhibition ELISA test for the detection of non-capsid polyprotein 3ABC in viral suspensions destined for inactivated foot-and-mouth disease vaccines. Dev Biol (Basel) 2006, 126:241-250. [discussion 327].
3. OIE. Foot and mouth disease. In: Office International des Epizooties/World Organisation for Animal Health SC, editor. Manual of standards for diagnostic tests and vaccines. Paris: Office International des Epizooties; 2008.
4. Russell W. The principles of humane experimental technique 1959, Methuen, London.
5. Maradei E., La Torre J., Robiolo B., Esteves J., Seki C., Pedemonte A., et al. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. Vaccine 2008, 26(December (51)):6577-6586.
6. Goris N., Maradei E., D'Aloia R., Fondevila N., Mattion N., Perez A., et al. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the " Protection against Podal Generalisation" test. Vaccine 2008, 26(June (27-28)):3432-3437.
7. Levings R.L., Henderson L.M., Metz C.A. In vitro potency assays for nonreplicating veterinary vaccines: comparison to in vivo assays and considerations in assay development. Vet Microbiol 1993, 37(November (3-4)):201-219.
8. Maas R.A., de Winter M.P., Venema S., Oei H.L., Claassen I.J. Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines. Vet Q 2000, 22(October (4)):223-227.
9. Van Maanen C., Terpstra C. Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies. Biologicals 1990, 18(October (4)):315-319.
10. Pecora A., Perez Aguirreburualde M.S., Rodriguez D., Seki C., Levy M.S., Bochoeyer D., et al. Development and validation of an ELISA for quantitation of bovine viral diarrhea virus antigen in the critical stages of vaccine production. J Virol Methods 2009, 162(December (1-2)):170-178.
11. Trotta M. Desarrollo y Evaluación de tecnología para la detección de Proteínas no Estructurales de Fiebre Aftosa en formulaciones vacunales [Development and evaluation of technology to detect non structural proteins of foot and mouth disease virus in vaccine formulations] 2010, University of San Martín, UNSAM, Buenos Aires.
12. Sorensen K.J., Hansen C.M., Madsen E.S., Madsen K.G. Blocking ELISAs using the FMDV non-structural proteins 3D, 3AB, and 3ABC produced in the baculovirus expression system. Vet Q 1998, 20(Suppl. 2):S17-20.
13. Brocchi E., Bergmann I.E., Dekker A., Paton D.J., Sammin D.J., Greiner M., et al. Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine 2006, 24(November (47-48)):6966-6979.
14. Wilson B. Recent development in periodate method of conjugating HRP to antibodies in immunofluorescence and related staining techniques 1978, Elsevier, Amsterdam.
15. Marzocca M.P., Seki C., Giambiagi S.M., Robiolo B., Schauer R., Dus Santos M.J., et al. Truncated E2 of bovine viral diarrhea virus (BVDV) expressed in Drosophila melanogaster cells: a candidate antigen for a BVDV ELISA. J Virol Methods 2007, 144(September (1-2)):49-56.
16. Robiolo B., Seki C., Fondevilla N., Grigera P., Scodeller E., Periolo O., et al. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests. Vaccine 2006, 24(February (7)):997-1008.
17. Capozzo A.V., Burke D.J., Fox J.W., Bergmann I.E., La Torre J.L., Grigera P.R. Expression of foot and mouth disease virus non-structural polypeptide 3ABC induces histone H3 cleavage in BHK21 cells. Virus Res 2002, 90(December (1-2)):91-99.
18. Balls M., Straughan D.W. The three Rs of Russell & Burch and the testing of biological products. Dev Biol Stand 1996, 86:11-18.
19. Grune B., Fallon M., Howard C., Hudson V., Kulpa-Eddy J.A., Larson J., et al. Report and recommendations of the international workshop " Retrieval approaches for information on alternative methods to animal experiments" ALTEX 2004, 21(3):115-127.